A new class of antibiotics, gepotidacin, has shown success in treating gonorrhea in late-stage trials. The antibiotic, made by pharmaceutical company GSK under the name Blujepa, has previously won FDA approval for uncomplicated UTIs in women and girls aged 12 and above. With rising cases of antibiotic-resistant gonorrhea in the US, gepotidacin, if approved, would be the first new drug for the infection since the 1990s.
Android 16 Comes with Advanced Device-level Security Setting Protection for 3 Billion Devices
Google has enhanced its Advanced Protection Program with Android 16, introducing advanced security for at-risk users like journalists and public figures. Key features include best-in-class
